RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BUONERBA C
Collezione AOU San Luigi di Orbassano

Items : 5

Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database. in Urologic oncology / Urol Oncol. 2024 Mar;42(3):69.e17-69.e25. doi: 10.1016/j.urolonc.2024.01.001. Epub 2024 Feb 1.

2024
AOU San Luigi di Orbassano

Porreca A; Di Nicola M; Lucarelli G; Dorin VM; Soria F; Terracciano D; Mistretta FA; Luzzago S; Buonerba C; Cantiello F; Mari A; Minervini A; Veccia A; Antonelli A; Musi G; Hurle R; Busetto GM; Del Giudice F; Ferretti S; Perdonà S; Prete PD; Porreca A; Bove P; Crisan N; Russo GI; Damiano R; Amparore D; Porpiglia F; Autorino R; et alii...

Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2023 Oct;21(5):574-583. doi: 10.1016/j.clgc.2023.05.017. Epub 2023 May 27.

2023
AOU San Luigi di Orbassano

Ferro M; Crocetto F; Tataru S; Barone B; Dolce P; Lucarelli G; Sonpavde G; Musi G; Antonelli A; Veccia A; Terracciano D; Busetto GM; Del Giudice F; Marchioni M; Schips L; Porpiglia F; Fiori C; Carrieri G; Lasorsa F; Verde A; Scafuri L; Buonerba C; Di Lorenzo G;

A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy. in Future oncology (London, England) / Future Oncol. 2021 Oct;17(30):3987-3994. doi: 10.2217/fon-2020-1298. Epub 2021 Jul 19.

2021
AOU San Luigi di Orbassano

Ferro M; Lucarelli G; de Cobelli O; Dolce P; Terracciano D; Musi G; Porreca A; Busetto GM; Del Giudice F; Soria F; Gontero P; Cantiello F; Damiano R; Crocerossa F; Abu Farhan AR; Autorino R; Vartolomei MD; Marchioni M; Mari A; Minervini A; Longo N; Celentano G; Chiancone F; Perdonà S; Del Prete P; Ditonno P; Battaglia M; Zamboni S; Antonelli A; et alii...

Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):796-802. doi: 10.23736/S2724-6051.20.04076-X. Epub 2021 Jan 13.

2021
AOU San Luigi di Orbassano

Ferro M; Marchioni M; Lucarelli G; Vartolomei MD; Soria F; Terracciano D; Mistretta FA; Luzzago S; Buonerba C; Cantiello F; Mari A; Minervini A; Veccia A; Antonelli A; Musi G; Hurle R; Busetto GM; Del Giudice F; Chung BI; Berardinelli F; Perdonà S; Del Prete P; Mirone V; Borghesi M; Porreca A; Bove P; Autorino R; Crisan N; Abu Farhan AR; et alii...

The emerging landscape of tumor marker panels for the identification of aggressive prostate cancer: the perspective through bibliometric analysis of an Italian translational working group in uro-oncology. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Aug;73(4):442-451. doi: 10.23736/S2724-6051.21.04098-4. Epub 2021 Mar 26.

2021
AOU San Luigi di Orbassano

Ferro M; Lucarelli G; de Cobelli O; Del Giudice F; Musi G; Mistretta FA; Luzzago S; Busetto GM; Buonerba C; Sciarra A; Conti S; Porreca A; Battaglia M; Ditonno P; Manfredi M; Fiori C; Porpiglia F; Terracciano D;